Comment Comment by dannykwells Note that this drug is not new - it is fully approved for ALK+ NSCLC and has been since 2015.It's not clear why these data are just coming out now or what is different from the original trials run in this setting.https://en.wikipedia.org/wiki/Lorlatinib parent dannykwells 2 years ago
It's not clear why these data are just coming out now or what is different from the original trials run in this setting.
https://en.wikipedia.org/wiki/Lorlatinib